Enliven Therapeutics Inc (NAS:ELVN)
$ 23.79 -0.63 (-2.58%) Market Cap: 1.19 Bil Enterprise Value: 950.25 Mil PE Ratio: 0 PB Ratio: 4.02 GF Score: 24/100

Q3 2020 Imara Inc Earnings Call Transcript

Nov 05, 2020 / 01:30PM GMT
Operator

Good morning and welcome to the Imara Inc. Q3 earnings conference call and webcast. (Operator Instructions)

I would now like to turn the conference over to Mr. Mike Gray. Sir, you may begin.

Mike Gray
Imara, Inc. - CFO & COO

Okay, thank you. Good morning, everyone and welcome to Imara's third-quarter 2020 conference call. I'd like to remind everyone that various statements we make during this conference call about the company's future expectations, plans and prospects, constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995.

Actual events or results could differ materially from those expressed or implied by these forward-looking statements as a result of various important factors, including those set forth in the Risk Factors section of our most recent quarterly report on Form 10-Q filed with the SEC this morning as well as any other filings that we make with the SEC.

Any forward-looking statements made on this call represent our views only as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot